This week on the Business RoundUp we catch up with Cem Zorlular, CEO of Er-Kim to discuss the global challenge of drug inequity. During this conversation, Cem breaks down the vast challenges of access to life saving pharmaceuticals especially in underserved areas of the world, plus: His own family experience with drug inequity and how it shaped his perspective on global drug access. How Er-Kim is a direct continuation of his family's legacy. Er-Kim's focus on rare disease treatments and why it's so crucial for low- and middle-income countries. How Western markets rarely see dramatic shifts, but such changes are commonplace globally. (natural disasters, economic volatility, war, etc.)  Given these significant challenges, what unique strategies/business models has Er-Kim developed to navigate these volatile environments and ensure a more consistent supply of medications. Don't miss this information packed episode!